SEARCH

SEARCH BY CITATION

  • 1
    Calkins, B. M., Lilienfeld, A. M., Garland, C. F. and Mendeloff, A. I., Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 1984. 29: 913920.
  • 2
    Elliott, D. E., Urban, J. F. J., Argo, C. K. and Weinstock, J. V., Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J. 2000. 14: 18481855.
  • 3
    Bentwich, Z., Weisman, Z., Moroz, C., Bar-Yehuda, S. and Kalinkovich, A., Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin. Exp. Immunol. 1996. 103: 239243.
  • 4
    Yazdanbakhsh, M., Kremsner, P. G. and van Ree, R., Allergy, parasites, and the hygiene hypothesis. Science 2002. 296: 490494.
  • 5
    Neurath, M. F., Fuss, I., Kelsall, B. L., Stuber, E. and Strober, W., Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995. 182: 12811290.
  • 6
    Elliott, D., Li, J., Blum, A., Metwali, A., Qadir, K., Urban, J. F. J. and Weinstock, J. V., Exposure to Schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. 2003. 284: G385–G391.
  • 7
    Moore, K. W., O'Garra, A., de Waal, M., Vieira, P. and Mosmann, T. R., Interleukin-10. Annu. Rev. Immunol. 1993. 11: 165190.
  • 8
    Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263274.
  • 9
    Berg, D. J., Davidson, N., Kuhn, R., Muller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W. and Rennick, D., Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 1996. 98: 10101020.
  • 10
    Berg, D. J., Zhang, J., Weinstock, J. V., Ismail, H. F., Earle, K. A., Alila, H., Pamukcu, R., Moore, S. and Lynch, R. G., Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002. 123: 15271542.
  • 11
    Price, P. and Turner, K. J., Nematospiroides dubius and Nippostrongylus brasiliensis: delayed type hypersensitivity responses to ovalbumin in the infected mouse. Exp. Parasitol. 1987. 63: 2131.
  • 12
    Price, P. and Holt, P. G., Immunological consequences of intestinal helminth infections: antigen presentation and immunosuppression by peritoneal cells. Aust. J. Exp. Biol. Med. Sci. 1986. 64: 399413.
  • 13
    Davidson, N. J., Hudak, S. A., Lesley, R. E., Menon, S., Leach, M. W. and Rennick, D. M., IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 1998. 161: 31433149.
  • 14
    Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 10571061.
  • 15
    Niessner, M. and Volk, B. A., Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 1995. 101: 428435.
  • 16
    Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C. and Strober, W., Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996. 157: 12611270.
  • 17
    Schreiber, S., Rosenstiel, P., Hampe, J., Nikolaus, S., Groessner, B., Schottelius, A., Kuhbacher, T., Hamling, J., Folsch, U. R. and Seegert, D., Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002. 51: 379385.
  • 18
    Liu, Z., Geboes, K., Heremans, H., Overbergh, L., Mathieu, C., Rutgeerts, P. and Ceuppens, J. L., Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur. J. Immunol. 2001. 31: 15501560.
  • 19
    Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K. et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000. 13: 715725.
  • 20
    Krajina, T., Leithauser, F., Moller, P., Trobonjaca, Z. and Reimann, J., Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur. J. Immunol. 2003. 33: 10731083.
  • 21
    Sveti, Madden, K. B., Zhou, X. D., Lu, P., Katona, I. M., Finkelman, F. D., Urban, J. F. J. and Gause, W. C., A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J. Immunol. 1993. 150: 34343441.
  • 22
    Urban, J. F. J., Katona, I. M., Paul, W. E. and Finkelman, F. D., Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci. USA 1991. 88: 55135517.
  • 23
    Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 23482357.
  • 24
    Powrie, F., Menon, S. and Coffman, R. L., Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 1993. 23: 22232229.
  • 25
    Zaccone, P., Phillips, J., Conget, I., Gomis, R., Haskins, K., Minty, A., Bendtzen, K., Cooke, A. and Nicoletti, F., Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 1999. 48: 15221528.
  • 26
    Doherty, T. M., Kastelein, R., Menon, S., Andrade, S. and Coffman, R. L., Modulation of murine macrophage function by IL-13. J. Immunol. 1993. 151: 71517160.
  • 27
    Woods, J. M., Amin, M. A., Katschke, K. J. J., Volin, M. V., Ruth, J. H., Connors, M. A., Woodruff, D. C., Kurata, H., Arai, K., Haines, G. K. et al., Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 2002. 13: 381393.
  • 28
    Khattri, R., Cox, T., Yasayko, S. A. and Ramsdell, F., An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003. 4: 337342.
  • 29
    Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330336.
  • 30
    von Herrath, M. G. and Harrison, L. C., Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 2003. 3: 223232.
  • 31
    Cowdery, J. S., Boerth, N. J., Norian, L. A., Myung, P. S. and Koretzky, G. A., Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J. Immunol. 1999. 162: 67706775.
  • 32
    Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A. and Klinman, D. M., CpG motifs in bacterial DNA trigger direct B cell activation. Nature 1995. 374: 546549.
  • 33
    Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P. and Trinchieri, G., Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 1995. 25: 672676.
  • 34
    Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156159.